Clinical Trials Directory

Trials / Unknown

UnknownNCT02209415

EUFURO - EUS-based Follow-Up on R0-resected Patients for Esophageal, Gastric and Pancreatic Cancer

Endoscopic Ultrasound (EUS) and PET-CT Based Follow-up of Patients Radically Resected for Cancer of the Oesophagus, Stomach or Pancreas.

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
182 (estimated)
Sponsor
Michael Bau Mortensen · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Follow-up after successful operative treatment of cancer in the esophagus, stomach or pancreas in order to detect recurrent disease is a controversial topic. This is because the methods and the consequence of following these patients is unknown. Therefore the investigators will randomize these patients in to two groups: 1. One group of patients will be offered visits with a specialist surgeon in a outpatient setting for a clinical evaluation every 3,6,9,12,18 and 24 months after surgery, as is the current standard at our department. 2. The other group will be offered Endoscopic UltraSound, EUS, and PET/CT with the same intervals as the first group.

Conditions

Interventions

TypeNameDescription
BEHAVIORALstandard follow-upOutpatient clinic visits
PROCEDUREPET/CT and EUSPET/CT and EUS

Timeline

Start date
2011-04-01
Primary completion
2016-01-01
Completion
2016-08-01
First posted
2014-08-05
Last updated
2014-08-05

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT02209415. Inclusion in this directory is not an endorsement.